Open AccessIDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
Author(s) -
Xiangli Chen,
Yanzi Zang,
Dujuan Li,
Jun Guo,
Yacai Wang,
Yuqi Lin,
Zhenghong Wei
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000019883
Subject(s) - medicine , aryl hydrocarbon receptor , rituximab , diffuse large b cell lymphoma , proportional hazards model , lymphoma , stage (stratigraphy) , gastroenterology , retrospective cohort study , oncology , paleontology , biochemistry , chemistry , biology , transcription factor , gene